Amelioration of diabetes by imatinib mesylate (Gleevec®): Role of β-cell NF-κB activation and anti-apoptotic preconditioning

FASEB Journal

Volumn 21, Issue 2, 2007, Pages 618-628

  Hägerkvist, Robert ^a   Sandler, Stellan ^a   Mokhtari, Dariush ^a   Welsh, Nils ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

c Abl; NO; Pancreatic islet

Indexed keywords

ABELSON KINASE; CYTOKINE; I KAPPA B; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; DIABETES MELLITUS; FEMALE; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; LYMPHOCYTE FUNCTION; MALE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED NOD; MICE, INBRED STRAINS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; STREPTOZOCIN;

ANIMALIA;

EID: 33846842100     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6910com     Document Type: Article

References (36)

1. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B. J., and Lydon, N. B. (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56, 100-104
2. Okuda, K., Weisberg, E., Gilliland, D. G., and Griffin, J. D. (2001) ARG tyrosine kinase activity is inhibited by STI571. Blood 97, 2440-2448
3. O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N. Engl. J. Med. 348, 994-1004
4. Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472-480
5. Veneri, D., Franchini, M., and Bonora, E. (2005) Imatinib and regression of type 2 diabetes. N. Engl. J. Med. 352, 1049-1050
6. Breccia, M., Muscaritoli, M., Aversa, Z., Mandelli, F., and Alimena, G. (2004) Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. J. Clin. Oncol. 22, 4653-4655
7. Van Etten, R. A. (1999) Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 9, 179-186
8. Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., and Kufe. D. (2000) Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J. Biol. Chem. 275, 17237-17240
9. Raina, D., Mishra, N., Kumar, S., Kharbanda, S., Saxena, S., and Kufe, D. (2002) Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-β-D- arabinofuranosylcytosine. Mol. Pharmacol. 61, 1489-1495
10. Wang, J. Y., and Ki, S. W. (2001) Choosing between growth arrest and apoptosis through the retinoblastoma tumour suppressor protein, Abl and p73. Biochem. Soc. Trans. 29, 666-673
11. Raina, D., Pandey, P., Ahmad, R., Bharti, A., Ren, J., Kharbanda, S., Weichselbaum, R., and Kufe, D. (2005) c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J. Biol. Chem. 280, 11147-11151
12. Mathis, D., Vence, L., and Benoist, C. (2001) β-Cell death during progression to diabetes. Nature 414, 792-798
13. Kolb, H., and Mandrup-Poulsen, T. (2005) An immune origin of type 2 diabetes? Diabetologia 48, 1038-1050
14. Atkinson, M. A., and Leiter, E. H. (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5, 601-604
15. Rakieten, N., Rakieten, M. L., and Nadkarni, M. R. (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91-98
16. Riksen, N. P., Smits, P., and Rongen, G. A. (2004) Ischaemic preconditioning: from molecular characterisation to clinical application-part I. Neth. J. Med. 62, 353-363
17. Welsh, N., Eizirik, D. L., Bendtzen, K., and Sandler, S. (1991) Interleukin-1b induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129, 3167-3173
18. Saldeen, J. (2000) Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141, 2003-2010
19. Saldeen, J., and Welsh, N. (1994) Interleukin-1β induced activation of NF-κB in insulin producing RINm5F cells is prevented by the protease inhibitor tosyl-lysine chloromethyl ketone. Biochem. Biophys. Res. Commun. 203, 149-155
20. Svensson, C., Borg, L. A. H., and Welsh, N. (1999) Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140, 3422-3428
21. Hägerkvist, R., Mokhtari, D., Myers, J. W., Tengholm, A., and Welsh, N. (2005) siRNA produced by recombinant dicer mediates efficient gene silencing in islet cells. Ann. N. Y. Acad. Sci. 1040, 114-122
22. Kawai, H., Nie, L., and Yuan, Z. M. (2002) Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl. Mol. Cell. Biol. 22, 6079-6088
23. Tobe, M., Isobe, Y., Tomizawa, H., Nagasaki, T., Takahashi, H., and Hayashi, H. (2003) A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. Bioorg. Med. Chem. 11, 3869-3878
24. Ghosh, S., Standen, N. B., and Galinanes, M. (2000) Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning. Cardiovasc. Res. 45, 934-940
25. Kwon, N. S., Lee, S. H., Choi, C. S., Kho, T. and Lee, H. S. (1994) Nitric oxide generation from streptozotocin. FASEB J. 8, 529-533
26. Kumar, S., Mishra, N., Raina, D., Saxena, S., and Kufe, D. (2003) Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571. Mol. Pharmacol. 63, 276-282
27. Kharbanda, S., Pandey, P., Yamauchi, T., Kumar, S., Kaneki, M., Kumar, V., Bharti, A., Yuan, Z. M., Ghanem, L., Rana, A., et al. (2000) Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol. Cell. Biol. 20, 4979-7989
28. Kumar, S., Bharti, A., Mishra, N. C., Raina, D., Kharbanda, S., Saxena, S., and Kufe, D. (2001) Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol. Cell. Biol. 21, 6233-6242
29. Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., Akira, S., Araki, E., and Mori, M. (2001) Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. U. S. A. 98, 10845-10850
30. Barbu, A., Welsh, N., and Saldeen, J. (2002) Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2. Mol. Cell. Endocrinol. 190, 75-82
31. Welsh, N. (1996) Interleukin-1β-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271, 8307-8312
32. Yellon, D. M., and Downey, J. M. (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83, 1113-1151
33. Baines, C. P., Cohen, M. V., and Downey, J. M. (1999) Signal transduction in ischemic preconditioning: the role of kinases and mitochondrial K(ATP) channels. J. Cardiovasc. Electrophysiol. 10, 741-754
34. Kullin, M., Li, Z., Bondo Hansen, J., Welsh, N., Karlsson, F. A., and Sandler, S. (2003) Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1β mediated suppression - possible involvement of the mitochondrial membrane potential. Diabetologia 46, 80-88
35. Hägerkvist, R., Makeeva, N., Elliman S., and Welsh, N. (2006) Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro. Cell Biol. Int. In press
36. Gottardi, M., Manzato, E., and Gherlinzoni, F. (2006) Gleevec and hyperlipidemia. N. Engl. J. Med. 353, 2722-2723